Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • PolarityTE Inc News

    0,0203 $ 0,00% +0,00 $
    In : 0,0190 € | 17.04.24 15:30:00 Nasdaq OTC Other aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A3DLAY
    ISIN: US7310942070
    US-Symbol: RGTPQ
    Typ: Aktie

    PolarityTE Inc News

    27.12.22 - PR Newswire
    PolarityTE Announces Entry Into a Letter of Intent For Acquisition of the Company
    PolarityTE Announces Entry Into a Letter of Intent For Acquisition of the Company PR Newswire
    10.11.22 - PR Newswire
    PolarityTE Reports Third Quarter 2022 Financial Results and Provides Business Update
    PolarityTE Reports Third Quarter 2022 Financial Results and Provides Business Update PR Newswire
    09.11.22 - PR Newswire
    PolarityTE Confirms Receipt of Unsolicited, Non-Binding Offer to Acquire the Company
    PolarityTE Confirms Receipt of Unsolicited, Non-​Binding Offer to Acquire the Company PR Newswire
    13.09.22 - PR Newswire
    PolarityTE to Present at the H.C. Wainwright 24th Annual Global Investment Conference on September 14, 2022
    PolarityTE to Present at the H.C. Wainwright 24th Annual Global Investment Conference on September 14, 2022 PR Newswire
    11.08.22 - PR Newswire
    PolarityTE Reports Second Quarter 2022 Financial Results and Provides Business Update
    PolarityTE Reports Second Quarter 2022 Financial Results and Provides Business Update PR Newswire
    01.08.22 - PR Newswire
    PolarityTE to Report Q2 2022 Financial Results on August 11, 2022
    PolarityTE to Report Q2 2022 Financial Results on August 11, 2022 PR Newswire
    06.06.22 - PR Newswire
    PolarityTE Announces $8.0 Million Registered Direct and Private Placement Offerings Priced At-The-Market Under Nasdaq Rules
    PolarityTE Announces $8.0 Million Registered Direct and Private Placement Offerings Priced At-​The-Market Under Nasdaq Rules PR Newswire
    23.05.22 - PR Newswire
    PolarityTE to Attend H.C. Wainwright Global Investment Conference
    PolarityTE to Attend H.C. Wainwright Global Investment Conference PR Newswire
    16.05.22 - PR Newswire
    PolarityTE to Effectuate 1-for-25 Reverse Stock Split
    PolarityTE to Effectuate 1-for-25 Reverse Stock Split PR Newswire
    16.05.22 - PR Newswire
    PolarityTE Reports First Quarter 2022 Financial Results and Provides Business Update
    PolarityTE Reports First Quarter 2022 Financial Results and Provides Business Update PR Newswire
    06.05.22 - PR Newswire
    PolarityTE to Report Q1 2021 Financial Results on May 16, 2022
    PolarityTE to Report Q1 2021 Financial Results on May 16, 2022 PR Newswire
    03.05.22 - PR Newswire
    PolarityTE Announces First Subject Enrolled in Phase III Pivotal Study Evaluating Investigational New Drug SkinTE® in Diabetic Foot Ulcers
    PolarityTE Announces First Subject Enrolled in Phase III Pivotal Study Evaluating Investigational New Drug SkinTE® in Diabetic Foot Ulcers PR Newswire
    13.04.22 - PR Newswire
    Thinking about buying stock in Agile Therapeutics, Polarityte, Bed Bath & Beyond, Tellurian, or Phio Pharmaceuticals?
    Thinking about buying stock in Agile Therapeutics, Polarityte, Bed Bath & Beyond, Tellurian, or Phio Pharmaceuticals? PR Newswire
    12.04.22 - PR Newswire
    Thinking about buying stock in Polarityte, RLX Technology, Bitnile, Aterian, or Cyclacel Pharmaceuticals?
    Thinking about buying stock in Polarityte, RLX Technology, Bitnile, Aterian, or Cyclacel Pharmaceuticals? PR Newswire
    30.03.22 - PR Newswire
    PolarityTE Reports Fiscal Year 2021 Financial Results and Provides Business Update
    PolarityTE Reports Fiscal Year 2021 Financial Results and Provides Business Update PR Newswire
    16.03.22 - PR Newswire
    PolarityTE Announces Closing of $5.0 Million Registered Direct Offering
    PolarityTE Announces Closing of $5.0 Million Registered Direct Offering PR Newswire
    16.03.22 - PR Newswire
    PolarityTE Announces $5.0 Million Registered Direct Offering
    PolarityTE Announces $5.0 Million Registered Direct Offering PR Newswire
    10.03.22 - PR Newswire
    PolarityTE to Report Fiscal Year 2021 Financial Results on March 30, 2022
    PolarityTE to Report Fiscal Year 2021 Financial Results on March 30, 2022 PR Newswire
    18.01.22 - PR Newswire
    Thinking about buying stock in Polarityte, Opko Health, Ion Geophysical, National CineMedia, or Playtika?
    Thinking about buying stock in Polarityte, Opko Health, Ion Geophysical, National CineMedia, or Playtika? PR Newswire
    18.01.22 - PR Newswire
    PolarityTE Announces U.S. FDA Approval of IND for Pivotal Phase 3 Study of SkinTE® to Support Chronic Cutaneous Ulcer Indication
    PolarityTE Announces U.S. FDA Approval of IND for Pivotal Phase 3 Study of SkinTE® to Support Chronic Cutaneous Ulcer Indication PR Newswire

    Newssuche

    Videos

    09:10 Uhr -3,35%
    Technical Trading: S&P 500 Short Chance
    S&P 500 Short Typ: Turbo Open End WKN: UH45D5 Hebel: 2,11 Laufzeit: OpenEnd Einstieg: Market ... Mehr »